Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Wilson

Showing results (351-360 of 403) with videos related to

Pageof 41
Sort By:
Journal of Medicinal Chemistry|June 21, 1996
Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxideH H Lee, W R Wilson, D M Ferry, et al.
Biochemical Pharmacology|September 7, 2000
Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolismB G Siim, K O Hicks, S M Pullen, et al.
British Journal of Cancer|January 1, 1997
An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumoursK O Hicks, S J Ohms, P L van Zijl, et al.
Annals of Internal Medicine|June 1, 1975
Prosthetic valve endocarditisW R Wilson, P M Jaumin, G K Danielson, et al.
The Journal of Infectious Diseases|December 23, 1999
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitisR Patel, M S Rouse, M V Florez, et al.
Journal of Medicinal Chemistry|April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.
Journal of Medicinal Chemistry|December 25, 1992
Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxinsW A Denny, G J Atwell, P B Roberts, et al.
Anti-Cancer Drug Design|October 1, 1996
Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductaseG J Atwell, M Boyd, B D Palmer, et al.
Molecular and Biochemical Parasitology|November 1, 1994
The Onchocerca volvulus homologue of the multifunctional polypeptide protein disulfide isomeraseW R Wilson, R S Tuan, K J Shepley, et al.
The Annals of Thoracic Surgery|September 11, 1991
Resternotomy in patients with valved conduits adherent to the sternumS Y DeLeon, M N Ilbawi, K Tubeszewski, et al.
Pageof 41

Showing results (351-360 of 403) with videos related to

Sort By:
Pageof 41
Journal of Medicinal Chemistry|June 21, 1996
Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxideH H Lee, W R Wilson, D M Ferry, et al.
Biochemical Pharmacology|September 7, 2000
Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolismB G Siim, K O Hicks, S M Pullen, et al.
British Journal of Cancer|January 1, 1997
An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumoursK O Hicks, S J Ohms, P L van Zijl, et al.
Annals of Internal Medicine|June 1, 1975
Prosthetic valve endocarditisW R Wilson, P M Jaumin, G K Danielson, et al.
The Journal of Infectious Diseases|December 23, 1999
Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitisR Patel, M S Rouse, M V Florez, et al.
Journal of Medicinal Chemistry|April 25, 1997
Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.
Journal of Medicinal Chemistry|December 25, 1992
Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxinsW A Denny, G J Atwell, P B Roberts, et al.
Anti-Cancer Drug Design|October 1, 1996
Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductaseG J Atwell, M Boyd, B D Palmer, et al.
Molecular and Biochemical Parasitology|November 1, 1994
The Onchocerca volvulus homologue of the multifunctional polypeptide protein disulfide isomeraseW R Wilson, R S Tuan, K J Shepley, et al.
The Annals of Thoracic Surgery|September 11, 1991
Resternotomy in patients with valved conduits adherent to the sternumS Y DeLeon, M N Ilbawi, K Tubeszewski, et al.
Pageof 41